Business & Regulation

Why is the pharma industry so despised when it has saved countless lives?

Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model

The latest edition of the European Pharmacopoeia was published in July 2016 and some large changes are afoot.

Many people struggle with QbD, but there are secrets to success…

Today’s cleanrooms may meet current quality standards, but what about the future?

The technology behind cleanrooms is well over 50 years old. Is it time for a makeover?

The pharma industry can succeed post-Brexit if the right policies are put in place.

Researchers call for more oversight as some pharma companies cozy up to hemophilia patients.

The world’s most populous state is set for big things in patented (bio) pharmaceutical development.

A video game built about the pharma industry adds marketing and malpractice capabilities